Less than a decade after being hatched out of a Texas university, Houston-based Bellicum Pharmaceuticals is in the midst of clinical trials on two innovative cancer therapies that, if successful, could result in new ways of attacking and killing off harmful cells. The company uses a platform technology called chemical induction of dimerization, and is … Continue reading “Bellicum in Trials with Cancer Vaccine, Cell-Suicide Switches”